Who Might Buy Puma Biotechnology?

Puma Biotechnology (PBYI) is target of a perennial buy-out speculation, and with biotech acquisitions once again in the news, UBS analyst Matthew Roden and team consider potential acquirers, including Gilead Sciences (GILD), Johnson & Johnson (JNJ), and Sanofi (SNY): Recent media reports about a Pharmacyclics (PCYC) buyout have reinvigorated M&A discussion in biotech…We continue to see Puma as [...]